ATTD: Advanced Technologies and Treatments for Diabetes

• Toward the Cure of Type 1 Diabetes, ATTD 2025 Conference Catch-Up

  In this episode of ATTD 2025 Conference Catch-Up, we dive into Toward the Cure of Type 1 Diabetes, featuring exciting discussions on cutting-edge strategies, from gene therapy to biomaterials, aimed at advancing beta cell replacement and ultimately finding a cure for type 1 diabetes.Join us as we summarize key takeaways from these thought-provoking presentations:Biomaterials to Aid Beta Cell Replacement - Current and Future Perspectives – Dr. Victoria SalemNew Strategies for Curative Therapies for Diabetes – Prof. Stefan BornsteinUpdate on Efforts to Interdict Type 1 Diabetes – Dr. Desmond SchatzThis episode is an essential listen for endocrinologists, diabetes researchers, clinicians, and healthcare professionals interested in the latest advances in curative therapies, including gene therapy, biomaterials, and novel treatments aimed at reversing type 1 diabetes.Enjoy the listen!This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.https://attd.kenes.com

  --------  

  28:41
• Time in Tight Range: Primary Treatment Goal in Diabetes, ATTD 2025 Conference Catch-Up

  In this episode of ATTD 2025 Conference Catch-Up, we dive into View, Counterview: Time in Tight Range Should Be the Primary Treatment Goals and Outcome Measure in Diabetes, featuring a lively debate on the role of time in tight range as a primary treatment goal, weighing the benefits of advanced CGM technology against the potential psychological and practical challenges.Join us as we summarize key takeaways from these thought-provoking presentations:View – Dr. Anders CarlsonCounterview – Dr. Jeremy Pettus Rebuttal by Speaker Presenting View – Dr. Anders CarlsonRebuttal by Speaker Presenting Counterview – Dr. Jeremy PettusThis episode is an essential listen for endocrinologists, diabetes specialists, and healthcare professionals looking to explore the role of tight glycemic control in diabetes management, understand the advantages and challenges of using time in range as an outcome measure, and gain insight into the evolving landscape of diabetes care.Enjoy the listen!This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.https://attd.kenes.com

  --------  

  20:29
• Debate: Is There a Real Unmet Need for Continuous Ketone Monitoring?, ATTD 2025 Conference Catch-Up

  In this episode of ATTD 2025 Conference Catch-Up, we dive into Debate: Is There a Real Unmet Need for Continuous Ketone Monitoring?, featuring a compelling discussion on the potential benefits and challenges of continuous ketone monitoring, exploring its role in preventing diabetic ketoacidosis and its place in diabetes management.Join us as we summarize key takeaways from these thought-provoking presentations:View – Prof. Jennifer SherrCounterview – Dr. Steven EdelmanRebuttal by Speaker Presenting View – Prof. Jennifer SherrRebuttal by Speaker Presenting Counterview – Dr. Steven EdelmanThis episode is an essential listen for endocrinologists, diabetes specialists, and healthcare professionals looking to understand the potential clinical impact of continuous ketone monitoring in diabetes management, its role in preventing complications, and its future integration into patient care.Enjoy the listen!This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.https://attd.kenes.com

  --------  

  21:50
• AI-Driven Healthcare: Opportunities and Challenges, ATTD 2025 Conference Catch-Up

  In this episode of ATTD 2025 Conference Catch-Up, we dive into AI-Driven Healthcare: Opportunities and Challenges, featuring discussions on the transformative potential of AI in diabetes and hypertension management, along with the challenges of integrating machine learning into clinical practice while ensuring patient safety and regulatory compliance.Join us as we summarize key takeaways from these thought-provoking presentations:Artificial Intelligence (AI) for Diabetes Treatment: A Next Step of Systematic Review and Network Meta-Analyses? – Prof. Oliver SchnellData-Driven Machine Learning: Unlocking the Future of Closed-Loop Diabetes Care – Prof. Yao QinMultiomics Biomarkers for Improved Diagnosis of Endocrine Hypertension – Prof. Maria-Christina ZennaroThis episode is an essential listen for endocrinologists, diabetes specialists, data scientists, and healthcare professionals looking to explore the latest advancements in AI and machine learning technologies, and how they are shaping the future of personalized healthcare, diabetes management, and diagnostic accuracy.Enjoy the listen!This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.https://attd.kenes.com

  --------  

  27:10
• Debate: Adaptive Trials in the Post-Teplizumab Era, ATTD 2025 Conference Catch-Up

  In this episode of ATTD 2025 Conference Catch-Up, we dive into Debate: Adaptive Trials in the Post-Teplizumab Era: To Placebo or Not to Placebo?, featuring a lively discussion on the ethics and necessity of placebo-controlled trials in type 1 diabetes research, with a focus on adaptive trial designs and the future of treatment testing.Join us as we summarize key takeaways from these thought-provoking presentations:Yes, We Should Continue with Placebo – Prof. Colin DayanNo, We Should Use Only Active (Approved) Control – Dr. Laura JacobsenRebuttal by Speaker Presenting the Case for 'Yes' – Prof. Colin DayanRebuttal by Speaker Presenting the Case for 'No' – Dr. Laura JacobsenThis episode is an essential listen for researchers, clinicians, and diabetes specialists interested in the future of clinical trial design, the ethical considerations in testing new treatments, and the evolving landscape of type 1 diabetes research.Enjoy the listen!This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com

  --------  

  32:16

Más podcasts de Ciencias

Podcasts a la moda de Ciencias

Acerca de ATTD: Advanced Technologies and Treatments for Diabetes